Bomedical passed the listing review meeting for its ChiNext IPO; it is a provider of interventional treatment solutions for complex vascular diseases.

Zhito Finance APP has learned that on September 16, Guangdong Bomai Medical Technology Co., Ltd. (abbreviated as: Bomai Medical) passed the listing committee meeting of the Shenzhen Stock Exchange ChiNext Board. The IPO sponsor is CICC, and it plans to raise 1.2 billion yuan.